Press Releases

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Cerba Research has announced a Memorandum of Understanding (MoU) with Teddy Clinical Research Laboratory to lay the foundation for an in-depth discussion towards the creation of a Joint Venture (JV).

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SERDA therapeutics has submitted an Investigational New Drug Application (IND) to the US FDA on the 17th February for its lead product SN514 hydrogel, an innovative enzymatic wound debriding agent. Clinical studies are expected to start in Q2 2023.

mdgroup launches third fully compliant medical distribution centre in Europe

mdgroup launches third fully compliant medical distribution centre in Europe. Amsterdam logistics centre Horreum strengthens links in the clinical trial supply chain, streamlines hybrid and DCT conduct, and creates remarkable patient experiences.

pharma& chooses Generis’ CARA Life Sciences Platform to become the basis of its Regulatory, Quality and Legal Management System

Generis announces that pharma& has selected the CARA™ Life Sciences Platform as the basis for its Regulatory, Quality and Legal Management System.

CD Formulation: Pharmaceutical Analysis Brings More Confidence to Drug Development and GMP Manufacturing

Photoactive Polymers, Alternative Energy Materials, and Micro-Nano Electric Materials

Alfa Chemistry Newly Releases Catalyst Analysis, Screening, Manufacturing, and Characterization Services

Pharma Targeting Celebrates 10 years of Connecting People Intelligently

Pharma Targeting, the bespoke research house exclusively working with pharma and biotech service providers, is celebrating its 10-year anniversary in 2023. Launched as a small custom research agency - part of The Targeting Group - the company has grown exponentially in the past decade, with global offices now across the UK, Europe, Argentina and India, and employing nearly 300 people with a backbone of world class life science experts, business strategists and marketing consultants, along with 200 PhD analysts.

Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona

Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Specialist biometrics CRO are key sponsor and presenter at industry event to support continuous professional development in clinical data management

MIB Agents Awards $200,000 in Grants to Colorado-based Researchers Studying Pediatric Osteosarcoma

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, recently presented $100,000 each to Michael Leibowitz, MD, PhD from the University of Colorado Cancer Center and Dr. Daniel Regan, DVM, PhD, DACVP from the Flint Animal Cancer Center at Colorado State University, totaling $200,000 in research funds to move rare bone cancer research forward. Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Leibowitz on February 8 and Dr. Regan on February 9.

Verana Health Announces Release of Qdata Module for Non-Muscle Invasive Bladder Cancer RWE Analysis

Second Urology Qdata Module to Provide Real-World Evidence from more than 50,000 De-identified Patients in the American Urological Association’s (AUA) Quality Registry (AQUA)

Biopharma PEG Supplies Multi-arm PEG Derivatives Crosslinked Into Hydrogels

Huateng Pharma Supplies Tetrahydrocurcumin With Large Scale

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for pharmaceutical intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

RTsafe has announced that Spain’s Fundación Instituto Valenciano de Oncología has conducted its first simulated therapy for brain metastases using RTsafe’s patient-specific quality assurance process, PseudoPatient.

BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS

BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting and payments, announced their partnership today. Through the partnership, BSI Life Sciences’ Clinical Trial Management software BSI CTMS™ and Ledger Run’s unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

BOC Sciences Established Large-Scale Fermentation Tanks of Different Volumes

Amerigo Scientific Releases Optimal ZediXclusive TG6-ab ELISA (IgA) Kits to Detect TG6-Autoantibodies in Human Sera

Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA), optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac disease-related studies.

Dolomite Bio announces re brand to Do Bio

Dolomite Bio has re-branded with a new website, a new name, and a new focus.

Quotient Sciences Expands Formulation Development Capabilities To Further Accelerate Drug Development Timelines

Company increases laboratory capacity to meet customer demand for fully integrated drug development capabilities

NDA Group Names New Chief Financial Officer to Lead Financial Strategy and Growth

NDA Group announces the appointment of Erik Bech-Jansen as the new Chief Financial Officer.